India's Akums Drugs rises on deal with Canada-based Triple Hair

Akums Drugs and Pharmaceuticals

16/10/2024 07:19

** Akums Drugs and Pharmaceuticals  AKUM.NS  rises as much
as 5.5% to 929.10 rupees
    ** Co enters into license and distribution agreement with
Canada-based Triple Hair, a biotechnology firm that specializes
in developing therapies to curb hair loss
    ** Says AKUM granted exclusive rights to further develop and
market products recently innovated by Triple Hair in India
    ** More than 218,000 shares traded, 1.1x the 30-day avg
    ** Since listing in August, AKUM has risen 27%

 (Reporting by Ashish Chandra in Bengaluru)
 ((ashish.chandra@thomsonreuters.com (+91 7982114624))